Vanishing bile duct syndrome in Hodgkin's disease: case report
作者： Marta Soares Rossini , Irene Lorand-Metze , Gislaine Borba Oliveira , Cármino Antonio De Souza
DOI: 10.1590/S1516-31802000000500008
关键词:
摘要: CONTEXT: Liver damage is relatively common in patients affected by Hodgkin's disease. A smaller proportion of cases develops jaundice. Recently, the vanishing bile duct syndrome was described The mechanisms this severe complication have been poorly understood until now. OBJECTIVE: To describe a rare case intra-hepatic cholestasis due to syndrome. DESIGN: Case report. CASE REPORT: 38-year-old male patient biopsy showed no detectable Intra-hepatic found and none six portal tracts analyzed contained normal ducts. treatment based on conventional high-dose escalation chemotherapy. died from an irreversible liver failure while complete remission
sci-hub.se 参考文章(12)
J. Heathcote, L. Lilly, I. R. Wanless, Ibrahim Altraif, Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole. The American Journal of Gastroenterology. ,vol. 89, pp. 1230- 1234 ,(1994)
Geoffrey M. Forbes, Gary P. Jeffrey, Keith B. Shilkin, William D. Reed, Carbamazepine hepatotoxicity: Another cause of the vanishing bile duct syndrome Gastroenterology. ,vol. 102, pp. 1385- 1388 ,(1992) , 10.1016/0016-5085(92)90780-3
Claudio Galperin, M Eric Gershwin, None, Immunopathogenesis of Gastrointestinal and Hepatobiliary Diseases JAMA: The Journal of the American Medical Association. ,vol. 278, pp. 1946- 1955 ,(1997) , 10.1001/JAMA.1997.03550220152020
P. Burra, E. Elias, Vanishing bile duct syndrome. British Journal of Surgery. ,vol. 79, pp. 604- 605 ,(2005) , 10.1002/BJS.1800790704
Elaine Jaffe, Malignant lymphomas: pathology of hepatic involvement. Seminars in Liver Disease. ,vol. 7, pp. 257- 268 ,(1987) , 10.1055/S-2008-1040581
F. Cervantes, J. Briones, M. Bruguera, C. Font, J.-M. Grau, C. Rozman, E. Montserrat, Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients. Annals of Hematology. ,vol. 72, pp. 357- 360 ,(1996) , 10.1007/S002770050186
F Gottrand, F Cullu, F Mazingue, B Nelken, M Lecomte-Houcke, JP Farriaux, None, Intrahepatic cholestasis related to vanishing bile duct syndrome in Hodgkin's disease. Journal of Pediatric Gastroenterology and Nutrition. ,vol. 24, pp. 430- 433 ,(1997) , 10.1097/00005176-199704000-00013
Stefan G. Hubscher, Matthew A. Lumley, Elwyn Elias, Vanishing bile duct syndrome : a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma Hepatology. ,vol. 17, pp. 70- 77 ,(1993) , 10.1002/HEP.1840170114
Mervyn H. Davies, Rebecca F. Harrison, Elwyn Elias, Stefan G. Hübscher, Antibiotic-associated acute vanishing bile duct syndrome: A pattern associated with severe, prolonged, intrahepatic cholestasis Journal of Hepatology. ,vol. 20, pp. 112- 116 ,(1994) , 10.1016/S0168-8278(05)80476-3
P Klimo, J M Connors, MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease. Journal of Clinical Oncology. ,vol. 3, pp. 1174- 1182 ,(1985) , 10.1200/JCO.1985.3.9.1174